Hypogonadism, erectile dysfunction, and type 2 diabetes mellitus: what the clinician needs to know (Q37810422)

23 August 2017

Hypogonadism, erectile dysfunction, and type 2 diabetes mellitus: what the clinician needs to know (English)

1 reference

23 August 2017

0 references

1 reference

1 reference

Ronald Tamler

1

1 reference

PubMed ID

21084793

23 August 2017

Tatiana Deveney

series ordinal

2

1 reference

PubMed ID

21084793

23 August 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

23 August 2017

Postgraduate Medicine

1 reference

23 August 2017

122

1 reference

23 August 2017

6

1 reference

23 August 2017

165-175

1 reference

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

23 August 2017

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

A practical guide to male hypogonadism in the primary care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Identification of late-onset hypogonadism in middle-aged and elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Prevalence of hypogonadism in males aged at least 45 years: the HIM study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Serum androgen levels in black, Hispanic, and white men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Prevalence of symptomatic androgen deficiency in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

The prevalence of and risk factors for androgen deficiency in aging Taiwanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Low testosterone levels are common and associated with insulin resistance in men with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Testosterone concentration in young patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Association of endogenous sex hormones with diabetes and impaired fasting glucose in men: multi-ethnic study of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Testosterone concentrations in diabetic and nondiabetic obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Healthier lifestyle predicts higher circulating testosterone in older men: the Health In Men Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Sex hormone-binding globulin as an independent predictor of incident type 2 diabetes mellitus in men

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE EVALUATION AND TREATMENT OF MALE SEXUAL DYSFUNCTION: A COUPLE'S PROBLEM-2003 UPDATE

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Prevalence and risk factors for erectile dysfunction in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Association of glycemic control with risk of erectile dysfunction in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Erectile function in men with diabetes type 2: correlation with glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Predictors for erectile dysfunction among diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

A population-based, longitudinal study of erectile dysfunction and future coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Erectile dysfunction predicts coronary heart disease in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Diabetes, obesity, and erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Klinefelter's syndrome, type 2 diabetes and the metabolic syndrome: the impact of body composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Metabolic complications of androgen deprivation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

The triad of erectile dysfunction, hypogonadism and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Complications of androgen deprivation therapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Hypogonadotropic hypogonadism in erectile dysfunction associated with type 2 diabetes mellitus: a common defect?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Hypogonadotropic hypogonadism in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Low testosterone level is an independent determinant of endothelial dysfunction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Erectile dysfunction, obesity, insulin resistance, and their relationship with testosterone levels in eugonadal patients in an andrology clinic setting

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Hypothalamic interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6, mediate the endotoxin-induced suppression of the reproductive axis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Role of brain insulin receptor in control of body weight and reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Gonadal and adrenal androgen deficiencies as independent predictors of increased cardiovascular mortality in men with type II diabetes mellitus and stable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Standardization of testosterone measurements in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

The relationship between libido and testosterone levels in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

EAU Guidelines on erectile dysfunction: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Cardiovascular drug use and the incidence of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

How often do we ask about erectile dysfunction in the diabetes review clinic? Development of a neuropathy screening tool

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Adherence to Mediterranean diet and erectile dysfunction in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Sex hormones and sexual function in obese men losing weight

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Effects of a low-energy diet on sexual function and lower urinary tract symptoms in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Inhibin B in men with severe obesity and after weight reduction following gastroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Testosterone and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Improvement of the diabetic foot upon testosterone administration to hypogonadal men with peripheral arterial disease. Report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Effects of testosterone on sexual function in men: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

The role of testosterone in erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Adverse events associated with testosterone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

The dark side of testosterone deficiency: III. Cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Clomiphene citrate and enclomiphene for the treatment of hypogonadal androgen deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: who does and does not benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Treatment of symptomatic androgen deficiency: results from the Boston Area Community Health Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Lower testosterone levels predict incident stroke and transient ischemic attack in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Welcoming low testosterone as a cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Increased prevalence of prolonged QT interval in males with primary or secondary hypogonadism: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Low serum testosterone and mortality in male veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Testosterone and depression: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Free testosterone and risk for Alzheimer disease in older men

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Association of Testosterone and Estradiol Deficiency with Osteoporosis and Rapid Bone Loss in Older Men

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Low free testosterone predicts frailty in older men: the health in men study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

Low testosterone and anaemia in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2234

21 January 2018

Identifiers

DOI

10.3810/PGM.2010.11.2234

1 reference

23 August 2017

1 reference

PubMed ID

21084793